Jim Cramer on Abbott Laboratories (ABT): ‘Not Understood Very Well Because They’re Doing Tremendous Stuff When It Comes To Diabetes. People Don’t Seem To Care’
We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are ...
Jim Cramer reflects on how the Biden administration might have affected the market
CNBC's Jim Cramer on Thursday mused about how President Joe Biden impacted stocks and reviewed a prevalent question among ...
Jim Cramer says he supports healthcare stocks for their long-term value
CNBC’s Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and ...
Jim Cramer on Signet Jewelers Limited (SIG): ‘I Think This Is A Very CEO-led Company’
We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are ...
Jim Cramer's four big-picture questions for 2025
CNBC’s Jim Cramer on Friday opined on the uncertainty of 2025 and listed four of the most pressing macroeconomic questions he ...
Jim Cramer explains why the Nasdaq failed to rally on Monday
CNBC's Jim Cramer examined Monday's market action, saying the tech-heavy Nasdaq failed to rally largely due to a unique ...
Yahoo Finance23d
Jim Cramer on Vertex Pharmaceuticals Incporated (VRTX): ‘This Is Hardly Down For The Year. I Think It Can Still Go Lower’
In his second appearance on Squawk on the Street after the Fed's interest rate cut, Jim Cramer had a lot to say about the Fed's decision and the Personal Consumption Expenditure (PCE) data release.
Jim Cramer urges investors to sell volatile stocks in quantum computing: ‘I can't be part of this froth'
CNBC’s Jim Cramer on Wednesday told investors to be wary of market froth, especially volatile stocks related to quantum ...